Sg Americas Securities, LLC Day One Biopharmaceuticals, Inc. Transaction History
Sg Americas Securities, LLC
- $30.5 Billion
- Q1 2025
A detailed history of Sg Americas Securities, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 34,409 shares of DAWN stock, worth $227,443. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,409
Previous 68,374
49.68%
Holding current value
$227,443
Previous $866,000
68.48%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DAWN
# of Institutions
196Shares Held
76.7MCall Options Held
138KPut Options Held
208K-
Atlas Venture Life Science Advisors, LLC6.43MShares$42.5 Million14.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$39.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$38 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$30 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$26.8 Million0.14% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $486M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...